KURA - Kura Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KURA is currently covered by 10 analysts with an average price target of $19.79. This is a potential upside of $13.43 (211.16%) from yesterday's end of day stock price of $6.36.

Kura Oncology's activity chart (see below) currently has 77 price targets and 105 ratings on display. The stock rating distribution of KURA is 92.59% BUY and 7.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.58% with an average time for these price targets to be met of 255.56 days.

Highest price target for KURA is $40, Lowest price target is $10, average price target is $25.13.

Most recent stock forecast was given by LI WATSEK from CANTOR FITZGERALD on 26-Jun-2025. First documented stock forecast 16-Dec-2015.

Currently out of the existing stock ratings of KURA, 50 are a BUY (92.59%), 4 are a HOLD (7.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

22 days ago
(26-Jun-2025)

0/4 (0%)

$20.04 (201.20%)

Buy

$36

$29.72 (473.25%)

$36

28 days ago
(20-Jun-2025)

5/15 (33.33%)

$30.15 (515.38%)

376

Buy

$28

$21.72 (345.86%)

$28

1 months 14 days ago
(04-Jun-2025)

2/11 (18.18%)

$21.55 (334.11%)

296

Buy

$11

$4.72 (75.16%)

$32

2 months 16 days ago
(02-May-2025)

3/6 (50%)

$4.53 (70.02%)

64

Buy

$40

$33.72 (536.94%)

$40

2 months 20 days ago
(28-Apr-2025)

6/28 (21.43%)

$33.49 (514.44%)

372

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KURA (Kura Oncology) average time for price targets to be met?

On average it took 255.56 days on average for the stock forecasts to be realized with a an average price target met ratio 42.58

Which analyst has the current highest performing score on KURA (Kura Oncology) with a proven track record?

KONSTANTINOS APRILAKIS

Which analyst has the most public recommendations on KURA (Kura Oncology)?

Konstantinos Aprilakis has 10 price targets and 6 ratings on KURA

Which analyst is the currently most bullish on KURA (Kura Oncology)?

Konstantinos Aprilakis with highest potential upside - $35.88

Which analyst is the currently most reserved on KURA (Kura Oncology)?

Li Watsek with lowest potential downside - -$0

Kura Oncology in the News

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting...

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

Kura Oncology, Inc. – Submission seeks approval for the treatment of adult patients with relapsed or refractory AML with a NPM1 mutation – SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”), today announced Kura submitted a New Drug...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?